ADURO BIOTECH (ADRO) Covered Calls

ADURO BIOTECH covered calls Aduro Biotech Inc is a clinical-stage immuno-oncology company focused on the development of technology platforms designed to stimulate robust and durable immune responses against cancer.

You can sell covered calls on ADURO BIOTECH to lower risk and earn monthly income. Born To Sell's covered call screener gives you customized search capabilities across all possible covered calls but here are a couple of examples for ADRO (prices last updated Wed 4:16 PM ET):

ADURO BIOTECH (ADRO) Stock Quote
Last Change Bid Ask Volume P/E Market Cap
8.20 +0.30 8.05 8.20 201K - 0.6B
Covered Calls For ADURO BIOTECH (ADRO)
Expiration Strike Call Bid Net Debit Return
If Flat
Annualized
Return If Flat
Jun 15 7.5 0.90 7.30 2.7% 41.1%
Jul 20 7.5 1.10 7.10 5.6% 34.6%
Subscribers get access to the full covered call chain, and more features.

Want to make money with covered calls?  Sign Up For A Free Trial


Extended Business Description

Aduro BioTech, Inc. operates as a clinical-stage immuno-oncology company, which focuses on the development of technology platforms to stimulate an immune response against cancer. The company has ongoing clinical trials with its LADD platform in pancreatic cancer, mesothelioma and high-grade glioma and development programs in non-small cell lung cancer, ovarian cancer and prostate cancer. It is also developing clinical candidates using synthetic small molecule immune modulators that are designed to activate the intracellular STING receptor, a central mediator of the innate immune response. Aduro BioTech was founded in 2000 and is headquartered in Berkeley, CA.